Literature DB >> 2334152

Induction potential of fluconazole toward drug-metabolizing enzymes in rats.

K L Lavrijsen1, J M Van Houdt, D M Van Dyck, W E Meuldermans, J J Heykants.   

Abstract

The induction of drug-metabolizing enzymes in rat liver was studied after subchronic administration of the new triazole antifungal agent fluconazole. The administered doses were 10, 40, and 160 mg/kg per day for 7 days. Fluconazole behaved as a high-magnitude inducer and significantly increased cytochrome P-450 concentrations already at 10 mg/kg (+42%). Cytochrome P-450 induction by fluconazole was dose dependent and reached a value of 302% of the control value at the dose of 160 mg/kg. The induction effects on cytochrome P-450 were also reflected in the drug-metabolizing enzyme activities in hepatic microsomes of pretreated rats. Fluconazole (160 mg/kg per day) preferentially induced the demethylase activities of N,N-dimethylaniline and p-nitroanisole to 258 and 281% of the control values, respectively. The detoxification enzyme UDP-glucuronosyltransferase was significantly lowered by fluconazole at the highest dose. A possible link between the induction potential and the pharmacokinetic properties of triazole antifungal agents is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2334152      PMCID: PMC171605          DOI: 10.1128/AAC.34.3.402

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  29 in total

1.  AN ADAPTIVELY STIMULATED O-DEMETHYLATING SYSTEM IN RAT LIVER MICROSOMES AND ITS KINETIC PROPERTIES.

Authors:  K J NETTER; G SEIDEL
Journal:  J Pharmacol Exp Ther       Date:  1964-10       Impact factor: 4.030

2.  Pharmacokinetic evaluation of UK-49,858, a metabolically stable triazole antifungal drug, in animals and humans.

Authors:  M J Humphrey; S Jevons; M H Tarbit
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

Review 3.  Classes of hepatic microsomal mixed function oxidase inducers.

Authors:  R Snyder; H Remmer
Journal:  Pharmacol Ther       Date:  1979       Impact factor: 12.310

4.  Evidence for biochemically different types of vesicles in the hepatic microsomal fraction.

Authors:  Y Imai; A Ito; R Sato
Journal:  J Biochem       Date:  1966-10       Impact factor: 3.387

Review 5.  Genes for cytochrome P-450 and their regulation.

Authors:  M Adesnik; M Atchison
Journal:  CRC Crit Rev Biochem       Date:  1986

6.  Effects of phenobarbital, pregnenolone-16 alpha-carbonitrile, and 3-methylcholanthrene pretreatments on the distribution of NADPH-cytochrome c (P-450) reductase within the liver lobule.

Authors:  Y Taira; P Greenspan; G F Kapke; J A Redick; J Baron
Journal:  Mol Pharmacol       Date:  1980-09       Impact factor: 4.436

7.  Purification of liver microsomal cytochrome P-450 isozymes 3a and 6 from imidazole-treated rabbits. Evidence for the identity of isozyme 3a with the form obtained by ethanol treatment.

Authors:  D R Koop; M J Coon
Journal:  Mol Pharmacol       Date:  1984-05       Impact factor: 4.436

8.  Pregnenolone-16alpha-carbonitrile-inducible cytochrome P450 in rat liver.

Authors:  L S Birnbaum; M B Baird; H R Massie
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1976-11

9.  Induction of cytochrome P-450 by glucocorticoids in rat liver. II. Evidence that glucocorticoids regulate induction of cytochrome P-450 by a nonclassical receptor mechanism.

Authors:  E G Schuetz; P S Guzelian
Journal:  J Biol Chem       Date:  1984-02-10       Impact factor: 5.157

Review 10.  Ketoconazole. Mechanism of action, spectrum of activity, pharmacokinetics, drug interactions, adverse reactions and therapeutic use.

Authors:  J H Van Tyle
Journal:  Pharmacotherapy       Date:  1984 Nov-Dec       Impact factor: 4.705

View more
  6 in total

Review 1.  Effects of the antifungal agents on oxidative drug metabolism: clinical relevance.

Authors:  K Venkatakrishnan; L L von Moltke; D J Greenblatt
Journal:  Clin Pharmacokinet       Date:  2000-02       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of zidovudine. An update.

Authors:  E P Acosta; L M Page; C V Fletcher
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

3.  Ro 09-1470 is a selective inhibitor of P-450 lanosterol C-14 demethylase of fungi.

Authors:  Y Aoki; F Yoshihara; M Kondoh; Y Nakamura; N Nakayama; M Arisawa
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

4.  Effects of cytochrome p450 inhibitors on itraconazole and fluconazole induced cytotoxicity in hepatocytes.

Authors:  Nhareet Somchit; Chong Sock Ngee; Azhar Yaakob; Zuraini Ahmad; Zainul Amiruddin Zakaria
Journal:  J Toxicol       Date:  2009-07-16

Review 5.  Clinical pharmacokinetics of fluconazole.

Authors:  D Debruyne; J P Ryckelynck
Journal:  Clin Pharmacokinet       Date:  1993-01       Impact factor: 6.447

6.  Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.

Authors:  E Sampol; B Lacarelle; J F Rajaonarison; J Catalin; A Durand
Journal:  Br J Clin Pharmacol       Date:  1995-07       Impact factor: 4.335

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.